MDR_REPORT_KEY|MDR_TEXT_KEY|TEXT_TYPE_CODE|PATIENT_SEQUENCE_NUMBER|DATE_REPORT|FOI_TEXT|BRAND_NAME|CATALOG_NUMBER|DATE_RECEIVED|DATE_REMOVED_FLAG|DATE_RETURNED_TO_MANUFACTURER|DEVICE_AGE_TEXT|DEVICE_AVAILABILITY|DEVICE_EVALUATED_BY_MANUFACTUR|DEVICE_EVENT_KEY|DEVICE_OPERATOR|DEVICE_REPORT_PRODUCT_CODE|DEVICE_SEQUENCE_NO|EXPIRATION_DATE_OF_DEVICE|GENERIC_NAME|IMPLANT_FLAG|LOT_NUMBER|MANUFACTURER_D_ADDRESS_1|MANUFACTURER_D_ADDRESS_2|MANUFACTURER_D_CITY|MANUFACTURER_D_COUNTRY_CODE|MANUFACTURER_D_NAME|MANUFACTURER_D_POSTAL_CODE|MANUFACTURER_D_STATE_CODE|MANUFACTURER_D_ZIP_CODE|MANUFACTURER_D_ZIP_CODE_EXT|MODEL_NUMBER|OTHER_ID_NUMBER|filter
6233845|68040031|D|1||"PHYSICIAN REPORTS ""SLIGHT AMOUNT OF EFFUSION AROUND THE RIGHT IMPLANT AND SOME HARDENING WITH SOME CAPSULAR CONTRACTURE, GRADE III, DISTORTING THE BREAST"" AND GOES ON TO STATE ""FAIRLY THICK CAPSULE WITH SOME FLUID WITHIN IT, ALTHOUGH THE FLUID WAS CLEAR AND NOT IN ANY WAY MILKY. A TOTAL CAPSULECTOMY WAS CARRIED OUT AND SENT FOR HISTOLOGY."" HISTOPATHOLOGY REPORTS ""THE SPECIMEN COMPRISES A FIBROUS CAPSULE WITH ADHESIONS AND IRREGULARITY OVER THE EXTERNAL SURFACE"" AS WELL AS ""SECTIONS OF THE CAPSULE SHOW FIBROUS TISSUE WITH PATCHY MIXED INFLAMMATION."" HISTOPATHOLOGY CONFIRMS CD30+ AND ALK-. THIS IS NOW A CONFIRMED CASE OF ALCL."|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 110|01/09/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247187|66742202|D|1||"ADDITIONAL INFORMATION RECEIVED FROM THE HEALTH PROFESSIONAL REGARDING THE EVENT. IN THE MRI REPORT DATED (B)(6) 2016, ADDITIONAL REPORTED EVENT OF ""IMPLANT SURROUNDED BY A LARGE COLLECTION OF FLUID."" PATHOLOGY RESULTS FROM (B)(6) 2016 REVEALED ""LEFT PERIPROSTHETIC CAPSULE: ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED WITH BREAST IMPLANT."" PATHOLOGY SHOWS ALCL MARKERS OF CD30+ AND ALK-. PHYSICIAN ADDITIONALLY REPORTED EVENTS OF ""PAIN AND A FEELING OF LOCALIZED INFLAMMATION AROUND THE IMPLANT."" THE EVENT OF PAIN WILL BE NOT DEVICE RELATED AS IT IS A SECONDARY SYMPTOM TO OTHER REPORTED EVENTS."|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6559362|74887821|D|1||PHYSICIAN REPORTED CASE OF LYMPHOMA ALCL, PAIN, RUPTURE, LARGE SEROMA PRESENT FOR 2 YEARS, AND CAPSULAR CONTRACTURE, BAKER GRADE II. CD30+ AND ALK- CONFIRMED. MICROSCOPIC ANALYSIS FOUND CHRONIC INFLAMMATION AROUND A CAVITATION. PATIENT HAD A LEFT SIDE CAPSULECTOMY WITH IMPLANT REMOVAL AND REPLACEMENT. THESE EVENTS OCCURRED ON THE LEFT SIDE.|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM445|05/10/2017||||N|R||0HP|FTR|1.0|10/11/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2183997|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6744780|81082640|D|1||PHYSICIAN REPORTED LATE SEROMA IN IMPLANT BEARING WAS FOUND. PHYSICIAN REPORTED A CASE OF ALCL, CONFIRMED VIA CYTOLOGY OF FLUID IN THE IMPLANT CAPSULE ON THE LEFT SIDE. CD30+ HAS BEEN CONFIRMED, BUT ALL PATHOLOGICAL MARKERS HAVE NOT BEEN CONFIRMED; EVENT WILL BE REPORTED AS LYMPHOMA. TREATMENT UNKNOWN.|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSM520|07/26/2017||||N|R||0HP|FTR|1.0|10/04/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180982|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247063|73823203|D|1||ADDITIONAL INFORMATION RECEIVED FROM HEALTHCARE PROFESSIONAL CONFIRMING EVENT IS AGAINST THE LEFT SIDE DEVICE. CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED; THIS IS A CONFIRMED CASE OF ALCL. PHYSICIAN ADDITIONALLY REPORTED EVENT OF CAPSULAR CONTRACTURE AT PRESENTATION, BAKER GRADE UNKNOWN.|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/12/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6247063|73823203|D|1||ADDITIONAL INFORMATION RECEIVED FROM HEALTHCARE PROFESSIONAL CONFIRMING EVENT IS AGAINST THE LEFT SIDE DEVICE. CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED; THIS IS A CONFIRMED CASE OF ALCL. PHYSICIAN ADDITIONALLY REPORTED EVENT OF CAPSULAR CONTRACTURE AT PRESENTATION, BAKER GRADE UNKNOWN.|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSLP280|01/12/2017|||DA|*|*||0HP|FTR|1.0|05/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1845063|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6544056|74409596|D|1||"PHYSICIAN REPORTED EVENT OF LEFT SIDE ALCL TO (B)(6); CD30+ MARKER HAS BEEN CONFIRMED. PHYSICIAN REPORTED EVENTS OF PAIN, ""LOSS OF 10 KG IN 1 YEAR,"" ""RECURRENT LYMPHORREA,"" ""INCREASE IN VOLUME,"" ""TIGHTENING,"" ""PERIPHERAL INFLAMMATION,"" ""FIBRINOID NECROSIS,"" ""AXILLARY ADENOPATHY,"" ""ABUNDANT INTRACAPSULAR EFFUSION,"" ""MASS,"" AND ""ADENOFIBROMA."" PHYSICIAN ADDITIONALLY REPORTED ""THERE IS HYPERVASCULAR TISSUE THICKENING, VISIBLE BY THE QUASI-CIRCUMFERENTIAL CAPSULE BUT PREDOMINANT IN INFERIOR-INTERNAL AND SUPERIOR-EXTERNAL PROJECTION."" THIS ALCL CASE WILL BE CAPTURED AS LYMPHOMA, AS ALK NEGATIVE MARKER WAS NOT CONFIRMED. DEVICE WAS EXPLANTED."|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TRM310|05/04/2017||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1327562|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6275633|65693785|D|1||PT HAD MCGHAN 363LF SALINE FILLED IMPLANTS PLACED ON (B)(6) 2016. PRESENTED WITH LARGE RIGHT BREAST SEROMA ON (B)(6) 2016. ULTRASOUND GUIDED ASPIRATION OF SEROMA PERFORMED ON (B)(6) 2016 AFTER ULTRASOUND AND MRI SHOWED LARGE LOCULATED RIGHT BREAST FLUID COLLECTION. ASPIRATED FLUID SHOWED CD30+ AND ALK1 - CELLS, LEADING TO THE DIAGNOSIS OF ALCL. SHE HAD BILATERAL CAPSULECTOMIES AND REMOVAL OF IMPLANTS ON (B)(6) 2017. PATHOLOGY DID NOT REVEAL ANY EXTENSION OF THE ALCL INTO THE CAPSULAR. SHE IS CURRENTLY BEING WORKED UP BY OUR ONCOLOGISTS WERE AS WELL AS OUR GENETICISTS.|MCGHAN 363 LF||01/23/2017||||*|*||I|FWM|2.0||SALINE FILLED BREAST IMPLANTS||1262358|||||MCGHAN|||||363LF-300||True
6275633|65693785|D|1||PT HAD MCGHAN 363LF SALINE FILLED IMPLANTS PLACED ON (B)(6) 2016. PRESENTED WITH LARGE RIGHT BREAST SEROMA ON (B)(6) 2016. ULTRASOUND GUIDED ASPIRATION OF SEROMA PERFORMED ON (B)(6) 2016 AFTER ULTRASOUND AND MRI SHOWED LARGE LOCULATED RIGHT BREAST FLUID COLLECTION. ASPIRATED FLUID SHOWED CD30+ AND ALK1 - CELLS, LEADING TO THE DIAGNOSIS OF ALCL. SHE HAD BILATERAL CAPSULECTOMIES AND REMOVAL OF IMPLANTS ON (B)(6) 2017. PATHOLOGY DID NOT REVEAL ANY EXTENSION OF THE ALCL INTO THE CAPSULAR. SHE IS CURRENTLY BEING WORKED UP BY OUR ONCOLOGISTS WERE AS WELL AS OUR GENETICISTS.|MCGHAN 363 LF||01/23/2017||||Y|*||0HP|FWM|1.0||SALINE FILLED BREAST IMPLANTS||1157904|||||MCGHAN|||||363LF-300||True
2149068|2071941|D|1||"THE PATIENT HAD AUGMENTATION SURGERY, IMPLANT DATE AND DEVICE INFORMATION UNKNOWN AT THIS TIME. HOWEVER, SHE DID HAVE EXPLANT SURGERY JANUARY 2000 AND WAS REPLACED WITH 468 TEXTURED SALINE IMPLANT. THE PATIENT PRESENTS WITH ""LEFT SIDE SWELLING"" AND ENLARGEMENT. A COMPLETE CAPSULECTOMY WITH IMPLANT REMOVAL WAS PERFORMED ON (B)(6) 2011. CYTOLOGY WAS PERFORMED ON THE SEROMA; CYTOLOGY RESULTS SHOWS CD30+ ALK-. A CT SCAN OF CHEST/ ABDOMEN AND PELVIS WAS ALSO CARRIED OUT AND WAS NEGATIVE FOR DISEASE. AT THE TIME OF THIS REPORT, THERE IS NO PLAN FOR CHEMOTHERAPY OR RADIATION TREATMENT. AN ONGOING INVESTIGATION IS BEING CARRIED OUT ANY NEW INFORMATION WILL BE UPDATED AND FORWARDED ON ACCORDINGLY."|STYLE 468 SALINE FILLED BREAST IMPLANT|468-380|06/13/2011|||DA|N|R||0HP|FWM|1.0|12/19/2003|nan||548477|||GOLETA, NE|US|ALLERGAN||CA|||||True
2348522|61100521|N|1||MEDWATCH SUBMITTED TO THE FDA ON 07/16/2015. ADVERSE EVENT OF ALCL WAS REPORTED PREVIOUSLY BUT AS THERE IS NO PATHOLOGY OR FOLLOW-UP CONFIRMING CD30+ OR ALK-, THE EVENT WILL REMAIN REPORTABLE AS LYMPHOMA.|STYLE 68 SALINE FILLED BREAST IMPLANT|68-390|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/30/2010|nan||1316501|||GOLETA|US|ALLERGAN||CA|||||True
2076644|2025896|D|1||"SALES REPRESENTATIVE CALLED TO REPORT A CASE OF ALCL. HE REPORTED THAT THE PATIENT HAD A HISTORY OF LEFT BREAST CANCER 17-18 YEARS AGO AND HAD UNDERGONE A BILATERAL MASTECTOMY. THE RIGHT SIDE WAS FOR PROPHYLACTIC PURPOSES. THE PATIENT HAD ALLERGAN TISSUE EXPANDERS PLACED AND ONCE EXPANSION WAS COMPLETE, HAD 168 DEVICES IMPLANTED. HOWEVER, 3-4 YEARS AGO, THE PATIENT HAD REMOVAL AND REPLACEMENT OF THE 168 TO A 68 DEVICE. AT THIS TIME, THE REASON FOR REPLACEMENT IS UNKNOWN. IN (B)(6) 2011, THE PATIENT PRESENTED WITH RIGHT SIDE REDNESS AND EDEMA. A DRAIN WAS PLACED AND FLUID WAS SENT TO THE LAB FOR ANALYSIS. THE CYTOLOGY WAS ALCL+. THE SURGEON IS PLANNING ON A LYMPH NODE BIOPSY PENDING THE REMAINDER OF THE CYTOLOGY. ADDITIONAL INFORMATION WAS THEN REQUESTED BY THE HEALTHCARE PROFESSIONAL FOR CLARIFICATION. MEDICAL RECORDS WERE FORWARDED THAT DATE BACK TO (B)(6) 1987 WHEN THE PATIENT WAS ORIGINALLY DIAGNOSED WITH LEFT BREAST INTRADUCTAL CARINOMA. THE PATIENT HAD IMPLANTED A DOW-CORNING TISSUE EXPANDER 500 CC DEVICE PLACED FILLED WITH 60 CC OF SALINE. ON (B)(6) 1988, THE PATIENT RETURNED TO THE OPERATING ROOM FOR FIRST STAGE RECONSTRUCTION ON THE RIGHT SIDE. A DOW-CORNING TISSUE EXPANDER 600CC TISSUE EXPANDER WAS PLACED AND FILLED TO 180CC. ON (B)(6) 1988, BILATERAL SECOND STAGE RECONSTRUCTION WAS CARRIED OUT. THE TISSUE EXPANDERS WERE REMOVED AND SURGITEK HIGH PROFILE RECONSTRUCTIVE IMPLANTS WERE PLACED CONTAINING 200CC OF GEL AND 50CC OF SALINE IN THE CENTRAL COLUMN. THE TOTAL VOLUMES WERE 250CC ON THE RIGHT AND 270CC ON THE LEFT. THE PATIENT WAS TAKEN BACK TO THE OPERATING ROOM ON (B)(6) 1994 FOR A RIGHT RUPTURED BREAST IMPLANT AFTER A RECENT MRI REVEALS BILATERAL IMPLANT ABNORMALITIES. ONCE THE INCISION WAS MADE, THE SILICONE WAS ENCOUNTERED. ""IT SHOULD BE NOTED THAT WAS NOT TYPICAL COHESIVE GEL. THE FLUID WAS THE CONSISTENCY OF HONEY OR AUTOMOBILE OIL. IT FLOWED FREELY."" MCGHAN SALINE FILLED TEXTURED IMPLANTS, 168 WERE EMPLOYED ON BOTH SIDES. ""27-168-271 (B)(4) ON THE LEFT AND 27-168-241 (B)(4) ON THE RIGHT. ON (B)(6) 2011, THE PATIENT HAD A LEFT IMPLANT FAILURE. A CAPSULECTOMY AND IMPLANT REMOVAL AND REPLACEMENT WAS PERFORMED. DEVICE (B)(4) 27-168-271 WAS IMPLANTED ON THE LEFT SIDE. THE PATIENT RETURNS IN (B)(6) 2011 WITH COMPLAINTS OF RIGHT SIDE SPONTANEOUS EXPANSION THAT BEGAN ABOUT ONE MONTH PRIOR. SHE WAS AFEBRILE AND THERE WAS NO REDNESS PRESENT. ""THIS REPRESENTED A SEROMA, HOWEVER, THIS HAS NOT RESOLVED TO ANY SIGNIFICANT DEGREE IN THE PAST FOUR WEEKS. IT IS THEREFORE, ELECTED AT THIS TIME TO EXPLORE THE AREA, OBTAIN CYTOLOGY AND CULTURES AND PLACE A DRAIN."" THE CAPSULE WAS WINDOWED AND YELLOW FLUID WAS ENCOUNTERED. IT WAS ASPIRATED FOR CYTOLOGY, AEROBIC AND ANAEROBIC CULTURES WERE OBTAINED. THE MCGHAN IMPLANT WAS ENCOUNTERED BUT NOT REMOVED FROM THE WOUND. THERE WAS NO OVERT ABNORMALITY ON ITS SURFACE. PATHOLOGY RETURNED CONFIRMS CD30+ CD45 (SUBSET), CD4, CD25, AND VIMENTIN; ALK - ."|STYLE 168 SALINE FILLED BREAST IMPLANT|168-240|04/12/2011|||DA|N|R||0HP|FWM|1.0|09/01/1997|nan||2-507710|||GOLETA|US|ALLERGAN||CA|||||True
1999354|14966427|D|1||"INITIALLY, PT REPORTED RIGHT SIDE LYMPHOMA, DEFLATION, INFECTION, IRRITATION/INFLAMMATION WITH RIGHT BREAST IMPLANT. F/U WITH THE IMPLANTING SURGEON'S OFFICE NOTED THE PT WAS SEEN IN THE EMERGENCY ROOM FOR WHAT WAS THOUGHT TO BE A RIGHT BREAST ABSCESS OR AN INFECTION. THE PT WAS THEN SENT TO SEE THE IMPLANTING SURGEON, WHO PERFORMED AN ANTIBIOTIC WASH AND HAD THE PT HAVE AN ULTRASOUND AS WELL. OPERATIVE NOTES WERE REQUESTED AND STATE, ""ON THE RIGHT SIDE, ONCE INCISED, WE ENCOUNTERED A LARGE VOLUME OF PURULENT FLUID. THIS WAS SENT FOR CULTURE. WE FOUND A COMPLETELY DEFLATED SALINE IMPLANT. THE CAPSULE WAS ANGRY AND INFLAMED... THE PATHOLOGY FINAL DIAGNOSIS: ALCL; CD30+ ALK- INCLUDING CD45+. THE PT WAS TO SEE AN ONCOLOGIST AT A LATER DATE. ADDITIONAL INFO PROVIDED BY THE SURGEONS' OFFICES NOTES THAT THE PT WAS SEEN BY THE ONCOLOGIST AND BREAST IMPLANT THAT WAS REMOVED WAS DISCARDED."|STYLE 168 SALINE FILLED BREAST IMPLANT|168-800|02/14/2011||||N|R||0HP|FWM|1.0|08/01/1997|nan||2-505392|||GOLETA|US|ALLERGAN||CA|||||True
3134127|61102727|N|1||MEDWATCH SUBMITTED TO THE FDA ON 07/16/2015. ADVERSE EVENT OF ALCL WAS REPORTED PREVIOUSLY BUT AS THERE IS NO PATHOLOGY OR FOLLOW-UP CONFIRMING CD30+ OR ALK-, THE EVENT WILL REMAIN REPORTABLE AS LYMPHOMA.|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3031014|3257466|D|1||"HEALTHCARE PROFESSIONAL REPORTS IN AN ARTICLE A CASE OF SEROMA AND ALCL (THE LANCET 2012; 380: 1530.) WITHIN THE ARTICLE THE AUTHOR REPORTS ""IN (B)(4) 2010, A PREVIOUSLY HEALTHY (B)(6) WOMAN WITH TEXTURED SALINE BREAST IMPLANTS PLACED SUBPECTORALLY 8 YEARS AGO (FOR AESTHETIC PURPOSES), PRESENTED WITH 2-MONTH HISTORY OF A PAINLESS MASS UNDERNEATH HER LEFT ARM. PHYSICAL EXAMINATION SHOWED A SYMMETRICAL BREASTS WITH NO OVERLYING SKIN OR NIPPLE CHANGES. THERE WERE TWO LARGE MOBILE NODES PALPABLE IN THE LEFT AXILLA. INITIAL BREAST MAMMOGRAPHY AND ULTRASONOGRAPHY CONFIRMED LEFT AXILLARY LYMPHADENOPATHY BUT DID NOT SHOW ANY PERI-IMPLANT FLUID COLLECTION. BIOPSY OF THE LEFT AXILLARY MASS SHOWED FINDINGS CONSISTENT WITH CLASSIC HODGKIN'S LYMPHOMA, NODULAR SCLEROSING TYPE. IT LACKED TWO TYPICAL STAINS-CD15 AND PAX5. PET-CT SHOWED A 5-CM AREA OF PET-AVID LEFT AXILLARY LYMPHADENOPATHY. HODGKIN'S LYMPHOMA STAGE IA WAS DIAGNOSED. THE PT THEN HAD TWO CYCLES OF ADRIAMYCIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE (ABVD) AND 2000 GY OF FIELD RADIATION TO THE LEFT AXILLA. HER INITIAL TREATMENT WAS COMPLETED IN (B)(6) 2011. F/U CT SCAN IN (B)(6) 2011, SHOWED A DECREASE IN THE SIZE OF THE LEFT AXILLARY LYMPHADENOPATHY. UNILATERAL FLUID COLLECTION, HOWEVER, WAS NOTED AROUND THE LEFT BREAST IMPLANT (FIGURE). THE FLUID INCREASED IN SIZE AND SHE PRESENTED 6 MONTHS ALTER WITH LEAKAGE OF SEROUS FLUID FROM HER LEFT BREAST. CYTOLOGY OF THE PERI-IMPLANT FLUID SHOWED CD30+ LYMPHOMA CELLS OF INDETERMINATE LINEAGE. DIFFERENT DIAGNOSIS INCLUDED RECURRENT HODGKIN'S LYMPHOMA OR IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMA. REPEAT PET-CT SHOWED PET-AVID AREAS ON BILATERAL AXILLARY LYMPH NODES. BOTH IMPLANTS WERE REMOVED WITH CAPSULECTOMIES. IN (B)(6) 2011, SHE REPEAT PET-CT SHOWED PET-AVID AREAS IN BILATERAL AXILLARY LYMPH NODES. BOTH IMPLANTS WERE REMOVED WITH CAPSULECTOMIES. IN (B)(6) 2011, SHE WAS TREATED WITH FOUR CYCLES OF SALVAGE CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN FOR ASSUMED RECURRENT HODGKIN'S LYMPHOMA. F/U SONOGRAPHY OF THE LEFT BREAST 1 MONTH LATER SHOWED A HYPOECHOIC MASS. BIOPSY OF THE MASS SHOWED SIMILAR CELLS FROM THE PERI-IMPLANT FLUID, WHICH WERE CD30+ LYMPHOMA CELLS OF INDETERMINATE ORIGIN. THE MASS WAS RESECTED IN (B)(6) 2012, AND PATHOLOGICAL TESTS SHOWED (B)(6), SEROMA-ASSOCIATED (LARGE-CELL LYMPHOMA (ALK-NEGATIVE ALCL). A RETROSPECTIVE REVIEW OF ALL SIDES SHOWED LARGE CELLS CHARACTERISTIC OF ALK-NEGATIVE ALCL. SUBSTANTIAL OVERLAP IN MORPHOLOGY AND IMMUNOPHENOTYPE OF CELLS FROM THE INITIAL AXILLARY LYMPH NODE BIOPSY, THE PERI-IMPLANT FLUID AND THE FINAL LEFT BREAST MASS BIOPSY SUGGESTED THE SAME MANIFESTATIONS OF THE ALCL. THE PRESENTATION IS UNIQUE BECAUSE ALK-NEGATIVE ALCL PRESENTED WITH A PATHOLOGICAL AXILLARY LYMPH NODE INSTEAD OF THE TYPICAL PERI-IMPLANT SEROMA. OUR PT COMPLETED BRENTUXIMAB THERAPY FOR TREATMENT OF ALK-NEGATIVE ALCL. THE PT WAS LAST SEEN ON (B)(6) 2012 AND IS IN STABLE CONDITION."|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/15/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4385755|16883770|D|1||"HEALTH PROFESSIONAL REPORTED PT ""DEVELOPED AXILLARY, PERICAPSULAR, AND SUPRACLAVICULAR MASSES. DIAGNOSED AS CD30+ ALK-ALCL AND SYNCHRONOUS HODGKIN'S LYMPHOMA. TREATED WITH BILATERAL IMPLANT REMOVAL, CAPSULECTOMIES, CHEMOTHERAPY WITH CHOP X 3 ROUNDS, AND RADIATION TO THE AXILLA. FOLLOW UP IMAGING WITH CT SCAN, NO RECURRENCE OF DISEASE. REMAINS HEALTHY"". ALCL AFFECTED BREAST REPORTED AS ""UNILATERAL -LEFT"". HEALTH PROFESSIONAL ADDITIONALLY REPORTED CAPSULAR CONTRACTURE, BAKER GRADE III."|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385755|54780897|D|1||"HEALTH PROFESSIONAL REPORTED PATIENT ""DEVELOPED AXILLARY, PERICAPSULAR, AND SUPRACLAVICULAR MASSES. DIAGNOSED AS CD30+ ALK- ALCL AND SYNCHRONOUS HODGKIN'S LYMPHOMA. TREATED WITH BILATERAL IMPLANT REMOVAL, CAPSULECTOMIES, CHEMOTHERAPY WITH CHOP X 3 ROUNDS, AND RADIATION TO THE AXILLA. FOLLOW UP IMAGING WITH CT SCAN, NO RECURRENCE OF DISEASE. REMAINS HEALTHY."" ALCL AFFECTED BREAST REPORTED AS ""UNILATERAL - LEFT."" HEALTH PROFESSIONAL ADDITIONALLY REPORTED CAPSULAR CONTRACTURE, BAKER GRADE III."|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4680690|5622102|D|1||"MEDICAL STAFF REPORTED RIGHT SIDE DEVICE REMOVAL DUE TO ""ANATOMIC PATHOLOGICAL MACROBIOPSY OF A LUMP FROM THE UPPER RIGHT BREAST SHOWED PROLIFERATION OF LYMPHOMA WITH DIFFUSE LARGE B-CELL CD30+ ALK-."" ""THE MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERISTICS ARE IN FAVOR OF A LAGC CD30+ ALK-."" EVENT WAS ADDITIONALLY TREATED WITH ""J1C1BENDAMUSTINE PALLIATIVE."" ADDITIONAL REPORT OF ""DEATH OF THE PT DUE TO THE EVOLUTION OF THE DISEASE."""|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF140-440|04/09/2015|||DA|N|R||0HP|FTR|1.0|03/20/2012|nan||1408999|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4385750|20374001|D|1||"HEALTH PROFESSIONAL REPORTED PT ""DEVELOPED RAPID DELAYED SEROMA. DIAGNOSED AS CD30+ ALK- ALCL OF MALIGNANT EFFUSION. TREATED WITH BILATERAL IMPLANT REMOVAL, CAPSULECTOMIES, CHEMOTHERAPY WITH CHOP. F/U IMAGING WITH CT SCAN, NO RECURRENCE OF DISEASE ""ALCL AFFECTED BREAST REPORTED AS ""UNILATERAL - RIGHT"", STAGE IE."|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385750|55048878|D|1||"HEALTH PROFESSIONAL REPORTED PATIENT ""DEVELOPED RAPID DELAYED SEROMA. DIAGNOSED AS CD30+ ALK- ALCL OF MALIGNANT EFFUSION. TREATED WITH BILATERAL IMPLANT REMOVAL, CAPSULECTOMIES, CHEMOTHERAPY WITH CHOP. FOLLOW UP IMAGING WITH CT SCAN, NO RECURRENCE OF DISEASE."" ALCL AFFECTED BREAST REPORTED AS ""UNILATERAL - RIGHT,"" STAGE IE."|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385811|5262304|D|1||"HEALTH PROFESSIONAL REPORTED PT ""RECEIVED BILATERAL MASTECTOMIES. OF NOTE ON [PT'S] PATHOLOGY, CD30+ ALK-ALCL, STAGE IE , WAS FOUND IN THE CONTRALATERAL RIGHT BREAST AT TIME OF MASTECTOMY."""|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|NE||NE||||True
4385811|55591407|D|1||"HEALTH PROFESSIONAL REPORTED PATIENT ""RECEIVED BILATERAL MASTECTOMIES. OF NOTE ON [PATIENT'S] PATHOLOGY, CD30+ ALK- ALCL, STAGE IE, WAS FOUND IN THE CONTRALATERAL RIGHT BREAST AT TIME OF MASTECTOMY."""|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|NE||NE||||True
4627437|5593685|D|1||"HEALTH PROFESSIONAL REPORTED VIA VOLUNTARY MW5039349: ""ALCL CASE REPORT. HISTORY OF BILATERAL BREAST AUGMENTATION. PT [HAS] HX OF PAINFUL SWELLING OF LEFT BREAST AFTER A MAMMOGRAM. SHE THEN HAD INDURATION AND ERYTHEMA OF INFERIOR PORTION OF LEFT BREAST. PT UNDERWENT MRI AND SKIN BIOPSY OF THE INDURATED PORTION OF [THE] LEFT BREAST. BY REPORT, THE BIOPSY SHOWED INFLAMMATORY TISSUE, BUT NO MALIGNANCY. THE PT PRESENTED WITH INCREASED PAIN AND SWELLING OF [THE] LEFT BREAST. [THE] LEFT BREAST WAS FIRM, AND LARGER VOLUME THAN [THE] RIGHT BREAST. [PATIENT] HAD AN AREA 5 X 8 CM OF ERYTHEMA ALONG THE INFERIOR ASPECT OF THE LEFT BREAST."" UPON REMOVAL, ""[PATIENT] HAD DENSE FIBROSIS AND INDURATION OF THE SKIN AND UNDERLYING BREAST TISSUE ON THE LEFT. FROZEN SECTION PATHOLOGY WAS CONSISTENT WITH PROBABLE INFLAMMATORY CARCINOMA. ENTIRE CAPSULECTOMY PERFORMED BILATERALLY. ON THE LEFT, THE CAPSULE WAS THICK AND FIRM, AND THE IMPLANT WAS COMPLETELY DEFLATED. THE IMPLANT WAS SURROUNDED BY 250-300CC OF CREAM, MONOGENOUS YELLOW FLUID. THIS WAS SENT FOR CYTOLOGY. PROCEDURE WAS BILATERAL CAPSULECTOMY WITH REMOVAL OF IMPLANTS, AND CLOSURE OVER DRAINS. THE IMPLANTS WERE MCGHAN TEXTURED SALINE IMPLANTS, 270CC, APPEARED TO BE SHAPED IMPLANTS. NO OTHER IDENTIFYING MARKS ON IMPLANTS."" LYMPHOMA WILL BE CAPTURED UNTIL CONFIRMATION OF ALCL, CD30+ AND ALK-, IS RECEIVED."|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/23/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5285827|34095038|D|1||"ALLERGAN SALES REPRESENTATIVE REPORTED, ""A REVISION CASE ON A PATIENT THAT HAD ALLERGAN IMPLANTS...THERE WAS FLUID AROUND THE DEVICE AND THE OFFICE SENT THE FLUID OFF TO BE CULTURED. THE CULTURED FLUID CAME BACK POSITIVE FOR BREAST IMPLANT ASSOCIATED ALCL."" SIDE WAS UNSPECIFIED. FOLLOW-UP WITH HEALTH PROFESSIONAL CONFIRMED THAT THE REASON FOR SURGERY WAS ""THE LEFT BREAST KEPT GETTING LARGER AND LARGER, SWELLING."" PATHOLOGY NOTED ""OPAQUE ORANGE FLUID"" AND CONFIRMED PRESENCE OF CD30+ AND ALK-. PATHOLOGY ALSO NOTED :CLINICAL HISTORY: LEFT BREAST IMPLANT MALPOSITION."" ALCL HAS BEEN CONFIRMED."|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|12/10/2015|||DA|N|R||0HP|FWM|1.0|12/04/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1375592|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5285827|33170547|D|1||"ALLERGAN SALES REPRESENTATIVE REPORTED, ""A REVISION CASE ON A PATIENT THAT HAD ALLERGAN IMPLANTS...THERE WAS FLUID AROUND THE DEVICE AND THE OFFICE SENT THE FLUID OFF TO BE CULTURED. THE CULTURED FLUID CAME BACK POSITIVE FOR BREAST IMPLANT ASSOCIATED ALCL."" SIDE WAS UNSPECIFIED. FOLLOW-UP WITH HEALTH PROFESSIONAL CONFIRMED THAT THE REASON FOR SURGERY WAS ""THE LEFT BREAST KEPT GETTING LARGER AND LARGER, SWELLING."" PATHOLOGY NOTED ""OPAQUE ORANGE FLUID"" AND CONFIRMED PRESENCE OF CD30+ AND ALK-. PATHOLOGY ALSO NOTED :CLINICAL HISTORY: LEFT BREAST IMPLANT MALPOSITION."" ALCL HAS BEEN CONFIRMED."|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|12/10/2015|||DA|N|R||0HP|FWM|1.0|12/04/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1375592|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5061707|25188102|D|1||"HEALTH PROFESSIONAL REPORTED ""HISTORY L BREAST SIZE INCREASE. R/O SEROMA - ATYPICAL LEUKOCYTES, CD30+ ALK-."" TREATMENT REPORTED AS ""TOTAL CAPSULECTOMY & EXPLANTATION."" FOLLOW UP DIAGNOSTIC TESTS RECEIVED CONFIRMED PRESENCE OF SEROMA AND ALCL. BREAST ULTRASOUND STATES, ""375ML OF MINIMALLY TURBID, STRAW COLOURED FLUID WAS ASPIRATED."" CYTOPATHOLOGY OF THIS FLUID REPORTS, ""SPECIMEN RECEIVED: L BREAST ""20 ML OF CLEAR YELLOW FLUID"". CONCLUSION: RARE ATYPICAL LARGE CD30+ CELLS PRESENT. ""HISTOPATHOLOGY REPORT STATES, "" MICROSCOPIC DESCRIPTION: THE ATYPICAL CELLS ARE STRONGLY CD30 MEMBRANE EXPRESSING"" ALK-1 ARE NEGATIVE."" THE DIAGNOSES STATES, ""BREAST IMPLANT-ASSOCIATED LARGE CELL LYMPHOMA."""|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX125-370|09/08/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1331894|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4922479|6435381|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE DEVICE REMOVED DUE TO A SEROMA THAT SUDDENLY APPEARED WITH SWELLING OF MAMMARY FOR SEVERAL WEEKS. DURING REMOVAL OF RIGHT SIDE IMPLANT, A DOUBLE CAPSULE WAS FOUND. PATHOLOGICAL TESTING OF THE SEROMA AND CAPSULE REVEALED PATHOLOGICAL MARKERS CD30+ AND ALK- AND FOCAL INFLAMMATORY CHRONIC REARRANGEMENTS. THIS CONFIRMS DIAGNOSIS OF RIGHT SIDE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL).|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF120-270|07/16/2015|||DA|N|R||0HP|FTR|1.0|08/25/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE, GEL-FILLED||1126779|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4957654|55248981|D|1||ADDITIONAL INFORMATION PROVIDED BY HEALTHCARE PROFESSIONAL NOTES DIAGNOSTIC INFORMATION REPORTED CD30+ AND ALK-. PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE BEEN RECEIVED. PATIENT HAS SINCE RECEIVED (B)(4) ROUNDS OF CHOEP TREATMENT (B)(6) 2015-(B)(6) 2016, (B)(4) ROUNDS OF GDP TREATMENT (B)(6) 2016-(B)(6) 2016 AND (B)(4) ROUNDS OF BRENTUXIMAB, STARTING (B)(6) 2016 UNTIL PRESENT. A STEM CELL TRANSPLANT IS PLANNED FOR (B)(6) 2016.|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
6145512|61450146|D|1||PHYSICIAN REPORTED CLOUDY YELLOW FLUID FROM BREAST PROSTHESIS AND DIAGNOSIS OF ANAPLASTIC LARGE CELL LYMPHOMA. CYTOLOGICAL MARKERS CD30+ AND ALK- HAVE NOT BEEN CONFIRMED; AS SUCH, THIS EVENT WILL BE CAPTURED AS LYMPHOMA. DEVICE WAS EXPLANTED. THIS MEDWATCH IS FOR THE RIGHT SIDE DEVICE; SEE MANUFACTURER REPORT # 9617229-2016-00173 FOR LEFT SIDE REPORT.|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145512|63919661|D|1||"RECEIVED ADDITIONAL INFORMATION FROM PHYSICIAN REPORTING ""IN IMMUNOHISTOCHEMISTRY, THESE TUMOR CELLS, WHICH ARE STRICTLY LIMITED IN THE FIBRIN COATING, ARE CD30+ AND ALK-."" THIS EVENT HAS BEEN CONFIRMED AS ALCL. DIAGNOSIS OF ALCL OCCURRED ON (B)(6) 2016. PHYSICIAN ADDITIONALLY REPORTED ""INFLAMMATORY DERMAL CONNECTIVE TISSUE"" IN THE RIGHT SIDE, RIGHT SIDE PAIN AND CAPSULAR CONTRACTURE, BAKER GRADE II. THIS MEDWATCH IS FOR THE RIGHT SIDE DEVICE; SEE MANUFACTURER REPORT # 9617229-2016-00173 FOR LEFT SIDE REPORT."|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6106201|65086177|D|1||"PHYSICIAN REPORTS PATIENT WITH ""SWELLING"" IN LEFT BREAST, LEFT SIDE ""SEROMA FLUID"" AND CD30+ LYMPHOMA, ""TREATED AS BIA-ALCL."" TOTAL CAPSULECTOMY AND EXPLANT REPORTED. AT THIS TIME ALCL HAS NOT BEEN CONFIRMED BY THE PATHOLOGICAL MARKER ALK-; UNTIL ALLERGAN RECEIVES CONFIRMATION OF THE MARKERS THIS WILL BE TERM CODED AS LYMPHOMA."|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|11/16/2016||12/14/2016|DA|R|Y||0HP|FTR|1.0|07/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||225212|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6106201|60020511|D|1||"PHYSICIAN REPORTS PATIENT WITH ""SWELLING"" IN LEFT BREAST, LEFT SIDE ""SEROMA FLUID"" AND CD30+ LYMPHOMA, ""TREATED AS BIA-ALCL."" TOTAL CAPSULECTOMY AND EXPLANT REPORTED. AT THIS TIME ALCL HAS NOT BEEN CONFIRMED BY THE PATHOLOGICAL MARKER ALK-; UNTIL ALLERGAN RECEIVES CONFIRMATION OF THE MARKERS THIS WILL BE TERM CODED AS LYMPHOMA."|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|11/16/2016||12/14/2016|DA|R|Y||0HP|FTR|1.0|07/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||225212|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6153182|61700301|D|1||JOURNAL ARTICLE Â¿AXILLARY LYMPHADENOPATHY: AN OUTSTANDING PRESENTATION FOR BREAST IMPLANT-ASSOCIATED ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ REPORTS, Â¿WE REPORT THE CASE OF A [PATIENT] PRESENTING WITH AN AXILLARY LYMPHADENOPATHY 8 YEARS AFTER BREAST PROSTHESES IMPLANTATION. CLINICAL EXAMINATION, ULTRASOUND, AND MAGNETIC RESONANCE IMAGING DETECTED NO MAMMARY LESIONS. THE LYMPH NODE SHOWED INTRASINUSOIDAL INFILTRATION BY LARGE PLEOMORPHIC CELLS EXPRESSING CD30 AND LACKING ALK-IMMUNOREACTIVITY. TUMOR STAGING WAS NEGATIVE. CELLS WITH IDENTICAL FEATURES WERE FOUND IN THE IPSILATERAL PERIPROSTHETIC CAPSULE. THE PATIENT WAS TREATED WITH CHOP AND RADIOTHERAPY, AND [PATIENT] IS ALIVE WITHOUT EVIDENCE OF DISEASE AFTER A 30-MONTH FOLLOW-UP.Â¿ FINE-NEEDLE ASPIRATION CYTOLOGY WAS TAKEN OF THE AXILLARY LYMPH NODE AND CD30+ / ALK- WAS CONFIRMED. DEVICE REMOVAL AND CAPSULECTOMY WAS PERFORMED. MANUFACTURER OF THE DEVICE IS UNKNOWN.|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5940718|69962843|D|1||HEALTHCARE PROFESSIONAL ADDITIONALLY REPORTED LEFT SIDE MASS AND INFLAMMATION. PATHOLOGICAL MARKERS CD30+ AND ALK- HAVE BEEN RECEIVED; THEREFORE, LYMPHOMA ALCL HAS BEEN CONFIRMED.|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6153188|61710212|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS (TABLE 1).Â¿ ARTICLE GOES ON TO STATE: Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA (BREAST IMPLANTÂ¿ASSOCIATED ALCL, 4.7 Ã 106 CELLS/MG OF TISSUE; CAPSULE, 4.9 Ã 106 CELLS/MG OF TISSUE). ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS. THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP. PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS (P < 0.05). IN CONTRAST, SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP. WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS (P < 0.001). BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATION.Â¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED. ACCORDING TO TABLE 1 Â¿CLINICAL SUMMARY OF BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTS,Â¿ THERE WERE 3 CASES OF ALCL WHERE THE PRESENTATION IS Â¿NOT KNOWN.Â¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION. THIS REPORT WILL CAPTURE 3 CASES OF ALCL WHERE THE PRESENTATION IS Â¿NOT KNOWN.Â¿|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5904549|59237866|D|1||ADDITIONAL INFORMATION: PATHOLOGY REPORTS SPECIFIES THAT THE FIBRINOID MATERIAL NEXT TO THE PROSTHESIS TESTED CD30+ AND ALK-. THIS IS NOW A CONFIRMED CASE OF ALCL AND HAS BEEN CAPTURED AS LYMPHOMA-ALCL.|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
5991152|59996591|D|1||GOVERNING BODY ADDITIONALLY REPORTED RIGHT SIDE CAPSULAR PAIN AT RIGHT SIDE, LYMPH NODE TUMOR SYNDROME, PRURITUS SINE MATERIAL, AXILLARY GANGLIONS, AND ANAPLASTIC LARGE CELL LYMPHOMA CD30+ ALK -.|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191866|62906213|D|1||"HEALTHCARE PROFESSIONAL REPORTED ""BREAST IMPLANTS REMOVED TODAY DUE TO ALCL."" SIDE WAS NOT SPECIFIED. THIS MEDWATCH REPRESENTS THE LEFT SIDE. SEE MFR # 9617229-2016-00248 FOR THE RIGHT SIDE."" AS PATHOLOGICAL MARKERS CONFIRMING ALK- AND CD30+ HAVE NOT BEEN RECEIVED, THE EVENT OF Â¿DUE TO ALCLÂ¿ WILL BE REPORTED AS LYMPHOMA."|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191866|67358311|D|1||"HEALTHCARE PROFESSIONAL REPORTED ""BREAST IMPLANTS REMOVED TODAY DUE TO ALCL."" SIDE WAS NOT SPECIFIED. AS PATHOLOGICAL MARKERS CONFIRMING ALK- AND CD30+ HAVE NOT BEEN RECEIVED, THE EVENT OF Â¿DUE TO ALCLÂ¿ WILL BE REPORTED AS LYMPHOMA. ADDITIONAL INFORMATION RECEIVED FROM THE HEALTHCARE PROFESSIONAL STATED PATIENT Â¿PRESENTED WITH LATE ONSET SEROMA LEFT BREAST. ASPIRATE CONFIRMED ATYPICAL CELLS, STRONGLY POSITIVE FOR CD30 T CELLS. ALK NEGATIVE. EMA POSITIVE."" THE DEVICE WAS EXPLANTED AND A CAPSULECTOMY WAS PERFORMED. THE LEFT SIDE SHOWED ""SMALL CLUSTERS OF ATYPICAL CELLS IN SURFACE MATERIAL ON CAPSULE (POSITIVE FOR CD30, EMA, CD4) BUT NO INVASION: EFFUSION ASSOCIATED ALCL.Â¿ PATHOLOGICAL MARKERS HAVE BEEN RECEIVED CONFIRMING ALCL. PATIENT ADDITIONALLY EXPERIENCED CAPSULAR CONTRACTURE, BAKER GRADE III. THIS MEDWATCH REPRESENTS THE LEFT SIDE."|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191882|62905365|D|1||"HEALTHCARE PROFESSIONAL REPORTED ""BREAST IMPLANTS REMOVED TODAY DUE TO ALCL."" SIDE WAS NOT SPECIFIED. THIS MEDWATCH REPRESENTS THE RIGHT SIDE. SEE MFR # 9617229-2016-00212 FOR THE LEFT SIDE."" AS PATHOLOGICAL MARKERS CONFIRMING ALK- AND CD30+ HAVE NOT BEEN RECEIVED, THE EVENT OF Â¿DUE TO ALCLÂ¿ WILL BE REPORTED AS LYMPHOMA."|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF145-490|12/20/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145514|61451048|D|1||PHYSICIAN REPORTED CLOUDY YELLOW FLUID FROM BREAST PROSTHESIS AND DIAGNOSIS OF ANAPLASTIC LARGE CELL LYMPHOMA. CYTOLOGICAL MARKERS CD30+ AND ALK- HAVE NOT BEEN CONFIRMED; AS SUCH, THIS EVENT WILL BE CAPTURED AS LYMPHOMA. DEVICE WAS EXPLANTED. THIS MEDWATCH IS FOR THE LEFT SIDE DEVICE; SEE MANUFACTURER REPORT (B)(4) FOR RIGHT SIDE REPORT.|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145514|64146443|D|1||"PHYSICIAN REPORTED FIRST LEFT BREAST SEROMA OCCURRING ON (B)(6) 2014 AND A SECOND LEFT BREAST SEROMA OCCURRING ON (B)(6) 2016. RECEIVED ADDITIONAL INFORMATION FROM PHYSICIAN REPORTING ANALYSIS OF SLIGHTLY CLOUDY ORANGE FLUID RESULTED IN LARGE CELLS TESTING CD30+ AND ALK-. PHYSICIAN ADDITIONALLY REPORTED ""IN IMMUNOHISTOCHEMISTRY, THESE TUMOR CELLS, WHICH ARE STRICTLY LIMITED IN THE FIBRIN COATING, ARE CD30+ AND ALK-."" THIS EVENT HAS BEEN CONFIRMED AS ALCL. DIAGNOSIS OF ALCL OCCURRED ON (B)(6) 2016. PHYSICIAN ADDITIONALLY REPORTED ""INFLAMMATORY COMPONENTS"" IN THE LEFT SIDE, LEFT SIDE PAIN AND CAPSULAR CONTRACTURE, BAKER GRADE II. THIS MEDWATCH IS FOR THE LEFT SIDE DEVICE; SEE MANUFACTURER REPORT # 9617229-2016-00174 FOR RIGHT SIDE REPORT."|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6180550|62543962|D|1||"PHYSICIAN REPORTED A PATIENT ""EXPERIENCED COMPLICATIONS 11 YEARS AFTER BREAST IMPLANTATION."" PHYSICIAN EXPLANTED DEVICE AND SENT A SAMPLE FOR TESTING. SAMPLE TESTED POSITIVE FOR ALCL. SIDE IS UNKNOWN. AT THIS TIME ALCL HAS NOT BEEN CONFIRMED BY THE PATHOLOGICAL MARKERS CD30+ AND ALK-; UNTIL ALLERGAN RECEIVES CONFIRMATION OF THE MARKERS THIS WILL BE REPRESENTED BY TERM CODE LYMPHOMA."|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/16/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5788476|53800763|D|1||"HEALTH PROFESSIONAL REPORTED ""BREAST VOLUME INCREASE, 5 YEARS AFTER REPLACEMENT AS PART OF MAMMARY MASTECTOMY. PERIPROSTHETIC EXTRAVASATION, REMOVAL OF PROSTHESIS + TOTAL CAPSULECTOMY. ANAPATH RESULTS: ALCL CONFIRMED."" SIDE WAS NOT SPECIFIED. FURTHER INFORMATION RECEIVED REPORTS, ""INCREASE OF THE VOLUME OF THE LEFT BREAST WITH EFFUSION DISCOVERED VIA MRI WITHOUT PROSTHETIC LEAK, WITHOUT REDNESS, NO PAIN OR FEVER. IMPLANT REMOVAL AND TOTAL CAPSULECTOMY. THE IMPLANT WAS FOUND INTACT. A SAMPLE IS TAKEN AND DIAGNOSIS OF ALCL-AIM CD30+ ALK- WILL BE DONE BY HISTOLOGICAL ANALYSIS, CONFIRMED BY THE NETWORK LYMPHOPATH."" PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED. PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED."|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5788476|51513752|D|1||"FURTHER INFORMATION RECEIVED REPORTS, ""INCREASE OF THE VOLUME OF THE LEFT BREAST WITH EFFUSION DISCOVERED VIA MRI WITHOUT PROSTHETIC LEAK, WITHOUT REDNESS, NO PAIN OR FEVER. IMPLANT REMOVAL AND TOTAL CAPSULECTOMIE. THE IMPLANT WAS FOUND INTACT. A SAMPLE IS TAKEN AND DIAGNOSIS OF ALCL-AIM CD30+ ALK- WILL BE DONE BY HISTOLOGICAL ANALYSIS, CONFIRMED BY THE NETWORK LYMPHOPATH."" PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED."|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6153200|61697779|D|1||LITERATURE ARTICLE Â¿COMPLETE SURGICAL EXCISION IS ESSENTIAL FOR THE MANAGEMENT OF PATIENTS WITH BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿87 PATIENTS WITH BI-ALCL, INCLUDING 50 PREVIOUSLY REPORTED IN THE LITERATURE AND 37 UNREPORTED.Â¿ ARTICLE CONTINUES TO STATE: Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMA (BI-ALCL) IS A RARE TYPE OF T-CELL LYMPHOMA THAT ARISES AROUND BREAST IMPLANTS. THE OPTIMAL MANAGEMENT OF THIS DISEASE HAS NOT BEEN ESTABLISHED. THE GOAL OF THIS STUDY IS TO EVALUATE THE EFFICACY OF DIFFERENT THERAPIES USED IN PATIENTS WITH BI-ALCL TO DETERMINE AN OPTIMAL TREATMENT APPROACH.Â¿ Â¿THE MEDIAN AND MEAN FOLLOW-UP TIMESWERE 45 AND 30 MONTHS, RESPECTIVELY (RANGE, 3 TO 217 MONTHS). THE MEDIAN OVERALL SURVIVAL (OS) TIME AFTER DIAGNOSIS OF BI-ALCL WAS 13 YEARS, AND THE OS RATE WAS 93%AND 89%AT 3 AND 5 YEARS, RESPECTIVELY. PATIENTS WITH LYMPHOMA CONFINED BY THE FIBROUS CAPSULE SURROUNDING THE IMPLANT HAD BETTER EVENT-FREE SURVIVAL (EFS) AND OS THAN DID PATIENTS WITH LYMPHOMA THAT HAD SPREAD BEYOND THE CAPSULE (P = .03). PATIENTS WHO UNDERWENT A COMPLETE SURGICAL EXCISION THAT CONSISTED OF TOTAL CAPSULECTOMY WITH BREAST IMPLANT REMOVAL HAD BETTER OS(P = .022) AND EFS(P = .014) THAN DID PATIENTS WHO RECEIVED PARTIAL CAPSULECTOMY, SYSTEMIC CHEMOTHERAPY, OR RADIATION THERAPY.Â¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED. THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH THERAPIES OR DEVICE TYPE. THIS REPORT WILL CAPTURE 37 UNREPORTED CASES OF ALCL- LYMPHOMA.|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153112|61699206|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS (TABLE 1).Â¿ ARTICLE GOES ON TO STATE: Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA (BREAST IMPLANTÂ¿ASSOCIATED ALCL, 4.7 Ã 106 CELLS/MG OF TISSUE; CAPSULE, 4.9 Ã 106 CELLS/MG OF TISSUE). ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS. THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP. PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS (P < 0.05). IN CONTRAST, SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP. WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS (P < 0.001). BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATION.Â¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED. ARTICLE FURTHER STATES: Â¿NONTUMOR CAPSULE SPECIMENS FROM 62 PATIENTS UNDERGOING REVISION SURGERY FOR HIGH-GRADE CAPSULAR CONTRACTURE.Â¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE. THIS REPORT WILL CAPTURE 62 CASES OF NONTUMOR NON ALCL CAPSULAR CONTRACTURE.|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153076|61697271|D|1||"LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS (TABLE 1).Â¿ ARTICLE GOES ON TO STATE: Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA (BREAST IMPLANTÂ¿ASSOCIATED ALCL, 4.7 Ã 106 CELLS/MG OF TISSUE; CAPSULE, 4.9 Ã 106 CELLS/MG OF TISSUE). ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS. THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP. PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS (P < 0.05). IN CONTRAST, SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP. WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS (P < 0.001). BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATION.Â¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED. ARTICLE ADDITIONALLY REPORTS: Â¿COMPARED WITH CLASSIC SYSTEMIC ALCL, BREAST IMPLANTÂ¿ ASSOCIATED ALCL BEHAVES IN A MORE INDOLENT MANNER AND IS DIVIDED INTO PATHOLOGIC VARIETIES: THE SEROMA-TYPE, CONSISTING OF EFFUSIONS WITH AN ENCAPSULATING MARGIN OF CD30+ MALIGNANT LYMPHOCYTES."" THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION. THIS REPORT WILL CAPTURE 12 CASES OF ALCL WHICH PRESENTED AS EFFUSION."|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6139164|61260979|D|1||"JOURNAL ARTICLE 'MARKED EOSINOPHILIA AS INITIAL PRESENTATION OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA' REPORTS, ""WE HERE DESCRIBE A CASE OF BI-ALCL IN A [PATIENT] WHO PRESENTED WITH HYPEREOSINOPHILIA AND DIFFUSE PRURITUS. [PATIENT] PRESENTED WITH DISCOMFORT AND MODERATE PAIN IN [THE] LEFT BREAST, AND A DIAGNOSIS OF CHRONIC SEROMA WAS MADE"" IN LEUKEMIA & LYMPHOMA, 57:11, 2712-2715. DEVICE WAS REMOVED AND REPLACED WITH ""TEXTURED IMPLANT (ALLERGAN)."" PATIENT'S SYMPTOMS PERSISTED AND THE REPLACEMENT IMPLANT WAS ALSO REMOVED. ARTICLE STATES, ""AS THE CHRONIC SEROMA CONTINUED, A TRU-CUT BIOPSY WAS CARRIED OUT THREE YEARS LATER BUT ONLY REVEALED CHRONIC INFLAMMATION.Â¿ ARTICLE GOES ON TO STATE ""A HISTOLOGICAL EXAMINATION OF THE PSEUDO-CAPSULE SHOWED THE DIFFUSE INFILTRATION OF LARGE CELLS WITH IRREGULAR, ANAPLASTIC OR Â¿EMBRYO-LIKEÂ¿ NUCLEI AND AN ABUNDANT EOSINOPHILIC GRANULAR CYTOPLASM."" THE ""MALIGNANT POPULATION"" TESTED FOR CD30+ AND ALK-1 EXPRESSION. ""AS BONE MARROW BIOPSY PERFORMED FOR STAGING PURPOSES WAS ALSO NEGATIVE, A DIAGNOSIS OF BI-ALCL WAS MADE."" THIS FILE REPRESENTS THE DEVICE REMOVED PREVIOUS TO ALCL."|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/01/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6153092|61703507|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS (TABLE 1).Â¿ ARTICLE GOES ON TO STATE: Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA (BREAST IMPLANTÂ¿ASSOCIATED ALCL, 4.7 Ã 106 CELLS/MG OF TISSUE; CAPSULE, 4.9 Ã 106 CELLS/MG OF TISSUE). ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS. THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP. PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS (P < 0.05). IN CONTRAST, SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP. WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS (P < 0.001). BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATION.Â¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED. ARTICLE ADDITIONALLY REPORTS: Â¿COMPARED WITH CLASSIC SYSTEMIC ALCL, BREAST IMPLANTÂ¿ ASSOCIATED ALCL BEHAVES IN A MORE INDOLENT MANNER AND IS DIVIDED INTO PATHOLOGIC VARIETIES:...THE LESS COMMON MASS-TYPE, WITH A MORE CLINICALLY AGGRESSIVE INFILTRATING TUMOR.Â¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION. THIS REPORT WILL CAPTURE 5 CASES OF ALCL WHICH PRESENTED AS TUMOR MASS.|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6157808|62108428|D|1||LITERATURE ARTICLE Â¿COMPREHENSIVE IMMUNOPHENOTYPIC ANALYSIS OF 64 CASES OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SHOWS AN ACTIVATED CYTOTOXIC WITH A SILENT T-CELL RECEPTOR PATTERNÂ¿ REPORTS Â¿64 CASES.Â¿ ARTICLE CONTINUES TO STATE: Â¿WE REVIEWED THE WORLD LITERATURE FOR CASES OF BI-ALCL AND ACCRUED CASES IN WHICH IMMUNOPHENOTYPIC DATA DERIVED USING IMMUNOHISTOCHEMICAL OR FLOW CYTOMETRY METHODS WERE USED AND AT LEAST 5 OF THE FOLLOWING 13 MARKERS WERE REPORTED: CD3, CD4, CD8, CD30, CD43, CD45, EMA,TIA-1, GRANZYME-B, ALK-1, TCR-Â¿Â¿ AND TCR-GÂ¿, AND EBER IN SITU HYBRIDIZATION. WHEN LESS THAN 5 MARKERS WERE REPORTED, WE CONTACTED CORRESPONDING AUTHORS FOR AVAILABLE MATERIAL, DID ADDITIONAL STUDIES, AND INCLUDED THESE DATA.Â¿ Â¿CD30 WAS POSITIVE IN ALL (N=64) CASES, WHEREAS ALK AND EBER WERE NEGATIVE IN ALL TESTED CASES, N=56 AND N=25, RESPECTIVELY. CD3 WAS POSITIVE IN 15 OF 62 (24%) CASES; CD4, 43/61 (70%); CD8, 6/57 (11%); CD43, 37/ 46 (80%); CD45, 29/49 (59%); EMA, 25/42 (60%); TIA-1, 28/46 (61%); GRANZYME-B, 28/ 47 (60%); TCR Â¿Â¿, 5/ 24 (21%); AND TCR GÂ¿ IN 1 OF 23 (4%). THUS TCR WAS SILENT IN 18/24 (75%) CASES.Â¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED. THIS RECORD HAS BEEN CREATED TO CAPTURE THE 56 CASES OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA.|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153118|61701317|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS (TABLE 1).Â¿ ARTICLE GOES ON TO STATE: Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA (BREAST IMPLANTÂ¿ASSOCIATED ALCL, 4.7 Ã 106 CELLS/MG OF TISSUE; CAPSULE, 4.9 Ã 106 CELLS/MG OF TISSUE). ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS. THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP. PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS (P < 0.05). IN CONTRAST, SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP. WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS (P < 0.001). BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATION.Â¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED. ACCORDING TO TABLE 1 Â¿CLINICAL SUMMARY OF BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTS,Â¿ THERE WAS 1 CASE OF ALCL PRESENT IN THE Â¿CAPSULE.Â¿ ARTICLE CLARIFIES THE Â¿CAPSULEÂ¿ CASE AS Â¿ONE PATIENT THE DIAGNOSIS OF BREAST IMPLANTÂ¿ASSOCIATED ALCL WAS AN INCIDENTAL FINDING WHILE UNDERGOING IMPLANT EXCHANGE FOR CAPSULAR CONTRACTURE.Â¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD TESTED NEGATIVE FOR BACTERIAL INFECTION. THIS REPORT WILL CAPTURE 1 CASE OF ALCL PRESENTED WITH Â¿CAPSULE,Â¿ REPRESENTED BY TERM CODE CAPSULAR CONTRACTURE.|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153187|61697756|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS (TABLE 1).Â¿ ARTICLE GOES ON TO STATE: Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA (BREAST IMPLANTÂ¿ASSOCIATED ALCL, 4.7 Ã 106 CELLS/MG OF TISSUE; CAPSULE, 4.9 Ã 106 CELLS/MG OF TISSUE). ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS. THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP. PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS (P < 0.05). IN CONTRAST, SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP. WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS (P < 0.001). BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATION.Â¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED. ACCORDING TO TABLE 1 Â¿CLINICAL SUMMARY OF BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTS,Â¿ THERE WAS 1 CASE OF ALCL WHICH PRESENTED WITH BOTH EFFUSION AND TUMOR. THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION. THIS REPORT WILL CAPTURE 1 CASE OF ALCL WHICH PRESENTED WITH BOTH EFFUSION AND TUMOR.|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
